High-grade B-cell lymphoma
Not recruitingStudy on the Effect of DA-EPOCH-R and Nivolumab in Patients with Newly Diagnosed High-Grade B-Cell Lymphoma with MYC and BCL2/BCL6 Rearrangements
Study on the Effect of DA-EPOCH-R and Nivolumab in Patients with Newly Diagnosed High-Grade B-Cell Lymphoma with MYC and BCL2/BCL6 Rearrangements
- Disease:High-grade B-cell lymphoma
- Substances:CyclophosphamideEtoposide+5
The Netherlands- Participants:18–64 years · 65+ years
- Substances:Cyclophosphamide
- Sponsor:Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting










